Medicare Part B drug payments to 340B hospitals “declined substantially” in 2019 because the payment status of “an unusually high number of drugs” changed that year, congressional Medicare advisers said in a report yesterday.
The change—from “pass-through status” to “separately
…
More than 70 percent of U.S. spending on top-selling “partial orphan drugs”—drugs for rare diseases that also are approved to treat common diseases—is for non-orphan indications, a study in latest edition of Health Affairs concludes.
Makers of partial orphan drugs
…
The ability to generate profits through the 340B program prompts hospitals to buy physician practices and shift delivery of care to more costly hospital outpatient settings, driving up drug costs for patients and employers, Pharmaceutical Research and Manufacturers of America
…
Half (50 percent) of a sample of health care industry C-suite executives surveyed last month expect the Biden administration to “formally obligate drug manufacturers to offer 340B pricing,” consulting firm Advis reports in its first health care industry leadership survey
…A message from 340B Report Publisher and CEO Ted Slafsky: We are pleased to have a sponsored content article today from Michael Gonzalez, President and Lead Consultant, FQHC340B, a valued 340B Report sponsor. I encourage you to read it. We will
…Happy Juneteenth from Publisher and CEO Ted Slafsky: Our sponsors are 340B’s industry leaders and we are proud to showcase their innovative solutions and guidance to help you implement and comply with this complex program. Benefits
…Editor’s note: Our next regularly scheduled edition will be on Thursday, May 28 due to the Memorial Day holiday weekend. We’ll publish an extra edition for any breaking news.
A note from 340B Report Publisher and
…A note from 340B Report CEO and Publisher Ted Slafsky: Today’s issue includes the fourth in our ongoing series of articles by 340B Report sponsors that draw on their deep expertise. Click on the button below
…A note from 340B Report CEO and Publisher Ted Slafsky: Today’s issue includes the third in our ongoing series of articles by 340B Report sponsors that draw on their deep expertise. Click on the button below
…*Sign up for news summaries and alerts from 340B Report
…